Meghan Lambie

Meghan is a hybrid experimental and computational biologist with a background in toxicology, molecular biology, and genomics. She completed her PhD in the department of Medical Biophysics at the University of Toronto focusing on the discovery of novel drug/radiation combinations to improve outcomes in squamous cancers. In her spare time, Meghan enjoys playing games with friends and family, biking, and reading.